ASSIGNMENT AGREEMENT THIS ASSIGNMENT AGREEMENT dated as of August 3, 2000, is entered into between Trinity Medical Group Co. Ltd., a Thai limited company (the "Assignor"), and Trinity Medical Group USA, Inc., a Florida corporation (the "Assignee"),...Assignment Agreement • December 22nd, 2000 • Trinity Medical Group Inc • Services-commercial physical & biological research
Contract Type FiledDecember 22nd, 2000 Company Industry
STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT dated as of September 15, 1995 (the "Agreement"), is entered into between THE IMMUNE RESPONSE CORPORATION, a Delaware corporation (the "Company"), having a place of business at 5935 Darwin Court,...Stock Purchase Agreement • December 22nd, 2000 • Trinity Medical Group Inc • Services-commercial physical & biological research • California
Contract Type FiledDecember 22nd, 2000 Company Industry Jurisdiction
ARTICLE 1 AMENDMENTLicense and Collaboration Agreement • December 22nd, 2000 • Trinity Medical Group Inc • Services-commercial physical & biological research • California
Contract Type FiledDecember 22nd, 2000 Company Industry Jurisdiction
TRINITY MEDICAL GROUP USA, INC. EMPLOYMENT AGREEMENT THIS AGREEMENT is made as of this 5th day of September, 2000 by and between GARY E. WILSON, residing at 31842 Camino Del Cielo, Trabuco Canyon, CA 92679 ("Executive"), and TRINITY MEDICAL GROUP USA,...Employment Agreement • December 22nd, 2000 • Trinity Medical Group Inc • Services-commercial physical & biological research • California
Contract Type FiledDecember 22nd, 2000 Company Industry Jurisdiction
EMPLOYMENT AGREEMENT After discussion, the Board of Directors have determined an agreement to employ Dr. James S. Namnath until December 31, 2000 as its Chief Executive Officer. His employment will be conducted under contract services with his present...Employment Agreement • December 22nd, 2000 • Trinity Medical Group Inc • Services-commercial physical & biological research
Contract Type FiledDecember 22nd, 2000 Company IndustryAfter discussion, the Board of Directors have determined an agreement to employ Dr. James S. Namnath until December 31, 2000 as its Chief Executive Officer. His employment will be conducted under contract services with his present employer, NotesETC, Inc. until such time ("Milestone") that TMGUSA either begins sale of Remune product or is approved for public trading of its common shares in the United States equity market as a reporting company; after this time, he will be directly employed by TMGUSA on a full time basis.